Lataa...
Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors
Recently, there is considerable interest in the field of anti-HIV therapy to identify and develop chromatin-modifying histone deacetylase (HDAC) inhibitors that can effectively reactivate latent HIV in patients. The hope is that this would help eliminate cells harboring latent HIV and achieve an eve...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3168425/ https://ncbi.nlm.nih.gov/pubmed/21838863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-8-400 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|